Loading...
01/11 03:13
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several concerns, including increased non-accruals, declining NAV, and rising interest expenses. Despite a strategic merger and investment-grade ratings, financial performance is hindered by tight market spreads and economic risks. The Q&A section highlights management's uncertainty regarding dividend support and leverage targets, adding to investor apprehension. While the dividend yield is attractive, the lack of a share repurchase program and unclear management responses contribute to a negative sentiment. The combination of these factors suggests a likely negative stock price movement in the near term.
GAAP net investment income $21 million (decreased by $0.04 per share from the prior quarter due to tighter yields from lower new issue spreads, lower base rates, and a modest uptick in non-accruals).
Adjusted net investment income $0.41 per share (decreased by $0.04 per share from the prior quarter, excluding one-time dividends from Credit Fund II).
Total investment income $55 million (generally in line with prior quarter due to a higher average portfolio balance, offset by lower weighted average yields and lower dividends from Credit Fund II).
Total expenses $33 million (increased due to higher interest expense from a higher average outstanding debt balance driven by portfolio growth).
Net asset value (NAV) per share $16.63 (decreased from $16.80 as of December 31).
Portfolio size Increased from $1.9 billion to $2.5 billion (due to net investment and strategic activity including the merger with CSL III and consolidation of Credit Fund II).
Dividend declared for Q2 2025 $0.40 per share (equal to the base dividend, representing an attractive yield of about 11% based on recent share price).
Total aggregate realized and unrealized net loss $8 million (partially attributable to a markdown on Maverick, offset by successful exit of SPF at par and markups in equity positions).
Non-accruals Increased to 1.6% of total investments at fair value (indicating some underperformance in a handful of names).
Statutory leverage About 1 turn (providing capacity to deploy capital into attractive opportunities).
Portfolio Growth: CGBD added approximately $180 million in organic originations to its portfolio.
Merger Impact: The merger with CSL III on March 27 resulted in approximately $490 million in new investments.
Portfolio Size Increase: The consolidation of Credit Fund II increased the portfolio size by a net $127 million.
Total Assets Growth: Total assets increased from $1.9 billion to $2.5 billion this quarter.
Dividend Declaration: The Board declared a second quarter dividend of $0.40 per share.
Credit Performance: Non-accruals increased to 1.6% of total investments at fair value.
Credit Fund Optimization: Consolidated Credit Fund II onto CGBD's balance sheet and extended investment period for Credit Fund I.
Capital Structure Improvement: Upsized and extended revolving credit facility by $145 million to $935 million.
Strategic Merger: The merger with CSL III is expected to improve liquidity and reduce costs.
Selective Underwriting Approach: CGBD remains selective in underwriting, focusing on quality credits.
Market Conditions: CGBD faced headwinds from declining base rates and historically tight market spreads, which could impact near-term earnings.
Tariff and Trade Policy: Recent volatility around tariffs is likely to remain a near-term headwind to overall capital markets and M&A activity, although direct exposure to tariffs is minimal (less than 5% of the portfolio).
Economic Growth: There is a broader risk of a slowdown in overall economic growth, which could affect demand for services and increase costs for companies.
Credit Performance: Non-accruals increased to 1.6% of total investments at fair value, indicating some underperformance in a handful of names.
Portfolio Risk: While the risk rating distribution improved, the company continues to actively assess portfolio companies for tariff risk exposure and potential secondary effects of reduced demand.
Debt and Financing: Increased interest expenses due to a higher average outstanding debt balance driven by portfolio growth could impact net investment income.
Merger with CSL III: The merger with CSL III closed on March 27, 2025, increasing CGBD's scale and eliminating preferred stock dilution, with Carlyle exchanging its investment at NAV.
Portfolio Growth: CGBD added approximately $180 million in organic originations and received $490 million in new investments from the CSL III merger, increasing total assets from $1.9 billion to $2.5 billion.
Credit Fund II Consolidation: The consolidation of Credit Fund II's assets onto CGBD's balance sheet increased the portfolio size by a net $127 million.
Focus on Credit Performance: CGBD is focused on overall credit performance and diversification, with 94% of investments in senior secured loans.
Optimizing Joint Ventures: CGBD is optimizing its joint ventures, including extending the investment period of Credit Fund I by three years.
Q2 2025 Dividend: The Board declared a second quarter dividend of $0.40 per share, maintaining the base dividend level.
Future NII Expectations: NII is expected to remain in the same range as Q1 2025, with a focus on maintaining a stable cash flow stream.
Portfolio Resilience: CGBD's portfolio remains resilient, with a focus on sourcing transactions with significant equity cushions and conservative leverage profiles.
Market Outlook: The company anticipates continued headwinds from market volatility and tariffs, but expects minimal direct risk from tariffs on the portfolio.
Leverage Capacity: Statutory leverage is about 1 turn, providing capacity to deploy capital into attractive opportunities.
Second Quarter Dividend: $0.40 per share, equal to the base dividend, payable to stockholders of record as of June 30, 2025.
Dividend Yield: Approximately 11% based on the recent share price.
Spillover Income: $0.85 per share of spillover income generated over the last five years.
Share Repurchase Program: None
The earnings call presents a mixed picture: stable investment income and improved credit performance are positive, but increased expenses and potential earnings troughs are concerning. The Q&A reveals management's focus on defensive strategies and long-term growth via JVs, but uncertainties in spread compensation and the lack of compelling opportunities for second lien debt are negative. Overall, the sentiment is neutral, as positives and negatives balance out, with no immediate catalysts for strong stock price movement.
The earnings call indicates growth through strategic mergers, increased investments, and successful restructuring, reducing nonaccruals. While unrealized losses due to credit issues are a concern, management's optimism about future opportunities and strong deal flow, along with stable dividends, suggest a positive outlook. The Q&A reveals no major negative sentiment, and management's cautious approach to stock buybacks and joint ventures aligns with their growth focus. Overall, the sentiment leans positive, predicting a 2% to 8% stock price increase.
The earnings call reveals several concerns, including increased non-accruals, declining NAV, and rising interest expenses. Despite a strategic merger and investment-grade ratings, financial performance is hindered by tight market spreads and economic risks. The Q&A section highlights management's uncertainty regarding dividend support and leverage targets, adding to investor apprehension. While the dividend yield is attractive, the lack of a share repurchase program and unclear management responses contribute to a negative sentiment. The combination of these factors suggests a likely negative stock price movement in the near term.
The earnings call summary shows mixed signals: a planned merger and stable dividends are positive, but expected earnings contraction and a net loss are concerning. The Q&A section reveals management's focus on the merger with unclear growth plans, adding uncertainty. The flat net investment income and total expenses, alongside a small net loss, suggest a stable but cautious outlook. With no market cap data, assuming a moderate reaction, the stock is likely to remain neutral in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
